Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracosactide for hemorrhagic shock in prehospital and in-hospital emergency care
2007-006445-41Phase 3Completed
- Sponsor
- NewCRO
- Start
- Jul 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tetracosactide hexaacetate in hemorrhagic shock (2 arms), sponsored by NewCRO. Started Jul 2012; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on 2007-006445-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006445-41.